Latest news
Categories
News archive
CEO Comment Q4 2024
14 February, 2025
SALES RECORD FOR CHROMTOGRAPHY PRODUCTS In 2024, we reached our highest sales of chromatography products ever with net sales of SEK 14.5 million, of which SEK 6.7 million in the fourth quarter. Sales of our silica media NLAB Saga® were able to start during the summer after we finalized and approved significantly larger volumes of silica than before from our large-scale production facility. Production of silica has continued to stabilize during the year, which has
Year-End Report 2024 Nanologica AB (publ)
14 February, 2025
FINANCIAL SUMMARY • Net sales for the fourth quarter amounted to SEK 6,715 thousand (75) and for the full year to SEK 14,538 thousand (1,443) • Operating loss for the quarter amounted to SEK -11,890 thousand (-35,638) and for the full year to SEK -59,255 thousand (-69,963). For the full year, operating profit was affected by write-downs of tangible and intangible assets totaling SEK 10,434 thousand (14,523). • Loss after tax for the quarter amounted
Change of Dates for Year-End Report 2024 for Nanologica AB
4 February, 2025
Due to technical reasons, Nanologica AB moves the year-end report for 2024 to Friday, February 14. The year-end report will be published on the company’s website at approximately 08.10. See press release
NANOLOGICA RECEIVES ORDER OF NLAB SAGA® WORTH APPX SEK 8.5 MILLION FROM RECURRING CUSTOMER IN CHINA
14 January, 2025
Nanologica has received yet another order for the company’s silica-based purification media NLAB Saga® from the Chinese pharmaceutical manufacturer Chengdu Shengnuo Biopharm Co. (“Shengnuo”). The order is worth approximately SEK 8.5 million and the customer uses Nanologica’s purification media in the production of a GLP-1 analogue. Since June 2024, Shengnuo has placed five orders of NLAB Saga® with a total value of approximately SEK 18 million. ”The Chinese market is very interesting for us and